 |
6,8-bis-benzylsulfanyl-octanoic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Myelodysplastic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2013-09-26 00:00:00 |
| Sponsor | Cornerstone Pharmaceuticals, Inc.;25 Health Science Drive;Stony Brook, New Mexico, 11790 |
